WO2023275046A1 - Transparent cosmetic composition with ascorbic acid, a cationic polymer and a glycol - Google Patents
Transparent cosmetic composition with ascorbic acid, a cationic polymer and a glycol Download PDFInfo
- Publication number
- WO2023275046A1 WO2023275046A1 PCT/EP2022/067721 EP2022067721W WO2023275046A1 WO 2023275046 A1 WO2023275046 A1 WO 2023275046A1 EP 2022067721 W EP2022067721 W EP 2022067721W WO 2023275046 A1 WO2023275046 A1 WO 2023275046A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- composition
- glycol
- composition according
- ascorbic acid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 109
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 70
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 229960005070 ascorbic acid Drugs 0.000 title claims abstract description 36
- 239000011668 ascorbic acid Substances 0.000 title claims abstract description 29
- 235000010323 ascorbic acid Nutrition 0.000 title claims abstract description 29
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 229920006317 cationic polymer Polymers 0.000 title claims abstract description 14
- 239000002537 cosmetic Substances 0.000 title claims abstract description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 28
- 229920000642 polymer Polymers 0.000 claims abstract description 23
- 229920002678 cellulose Polymers 0.000 claims abstract description 16
- 125000002091 cationic group Chemical group 0.000 claims abstract description 13
- 239000001913 cellulose Substances 0.000 claims abstract description 13
- 239000012736 aqueous medium Substances 0.000 claims abstract description 7
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 235000010980 cellulose Nutrition 0.000 claims description 15
- 229940051250 hexylene glycol Drugs 0.000 claims description 11
- -1 trimethylammonium halide Chemical group 0.000 claims description 10
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 9
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 9
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 8
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 8
- 239000002211 L-ascorbic acid Substances 0.000 claims description 7
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 6
- 102000011782 Keratins Human genes 0.000 claims description 5
- 108010076876 Keratins Proteins 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims description 4
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims description 4
- 229940067599 ascorbyl glucoside Drugs 0.000 claims description 4
- 150000002334 glycols Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 229940071097 ascorbyl phosphate Drugs 0.000 claims description 2
- AMQDHYXCJCIBQJ-YCWPWOODSA-L disodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2h-furan-4-yl] sulfate Chemical compound [Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OS([O-])(=O)=O)=C1[O-] AMQDHYXCJCIBQJ-YCWPWOODSA-L 0.000 claims description 2
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 claims description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 2
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 claims description 2
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 claims description 2
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 claims description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 claims 1
- 239000012071 phase Substances 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 125000000217 alkyl group Chemical group 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- QEHXDDFROMGLSP-VDBFCSKJSA-K trisodium;(2s)-2-[2-[[(1s)-1-carboxy-2-carboxylatoethyl]amino]ethylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].OC(=O)C[C@@H](C([O-])=O)NCCN[C@H](C([O-])=O)CC([O-])=O QEHXDDFROMGLSP-VDBFCSKJSA-K 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000003352 sequestering agent Substances 0.000 description 3
- 229940048081 trisodium ethylenediamine disuccinate Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- GDNCXORZAMVMIW-UHFFFAOYSA-N dodecane Chemical compound [CH2]CCCCCCCCCCC GDNCXORZAMVMIW-UHFFFAOYSA-N 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002634 lipophilic molecules Chemical class 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910000000 metal hydroxide Inorganic materials 0.000 description 2
- 150000004692 metal hydroxides Chemical class 0.000 description 2
- 229940031722 methyl gluceth-20 Drugs 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- VIHIKSJKXIMMLV-FZTHFCCHSA-M potassium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] phosphate Chemical compound [K+].C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OP([O-])(=O)OC1=C(O)[C@@H]([C@@H](O)CO)OC1=O VIHIKSJKXIMMLV-FZTHFCCHSA-M 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical group ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 125000006539 C12 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 101100256637 Drosophila melanogaster senju gene Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020682 bottled natural mineral water Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- PGQAXGHQYGXVDC-UHFFFAOYSA-N dodecyl(dimethyl)azanium;chloride Chemical group Cl.CCCCCCCCCCCCN(C)C PGQAXGHQYGXVDC-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000002243 furanoses Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068917 polyethylene glycols Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229940116905 potassium ascorbyl tocopheryl phosphate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000008132 rose water Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- Transparent cosmetic composition with ascorbic acid, a cationic polymer and a glycol
- the present invention relates to an aqueous transparent cosmetic composition, comprising at least 5% by weight of ascorbic acid and/or one of the derivatives thereof, at least 3.5% by weight of a glycol comprising 5 to 7 carbon atoms and at least one cationic polymer chosen from cationic cellulose polymers modified by groups including at least one linear fatty chain.
- vitamin C ascorbic acid
- Ascorbic acid is also known for the antioxidant properties thereof.
- ascorbic acid or one of the derivatives thereof is introduced into an aqueous medium at high levels (i.e., for example greater than 1% by weight, preferably greater than 5% by weight), the formulation thereof is difficult to carry out, as it destabilizes and changes color dramatically.
- compositions comprising ascorbic acid. It is possible to gel the aqueous phase of such compositions by means of a specific cationic polymer, preferably polyquaternium-67.
- This polymer has the triple advantage of adding viscosity to the medium and leaving a soft film on the skin and reducing the degradation of the color of ascorbic acid over time.
- serum or gelled solution type aqueous compositions have nevertheless the drawback of forming, when spread on the skin, a non-homogeneous deposit, which whitens during shearing, and which is not satisfactory for the consumer. Such whitening is referred to as "soaping" in the present application.
- an aqueous cosmetic composition comprising ascorbic acid and/or one of the derivatives thereof, which is stable, i.e., which stays the same color as originally (generally white) and the same texture, which does not degrade the active agent, and which does not exhibit soaping when applied.
- the Applicant demonstrated that associating a specific cationic polymer with hexylene glycol and/or pentylene glycol at a content of at least 3.5% by weight with respect to the total composition weight, makes it possible to obtain compositions comprising at least 5% by weight of ascorbic acid and/or one of the derivatives thereof, which are stable, and which do not exhibit soaping when applied.
- the present invention relates to a cosmetic composition
- a cosmetic composition comprising, in a physiologically acceptable aqueous medium:
- the composition has a pH between 5 and 7.
- the invention also relates to a cosmetic method for the care of keratin materials, preferably the skin, comprising the application of a composition according to the invention on said keratin materials.
- physiologically acceptable medium denotes a medium comprising water and compatible with the skin, mucosa and/or appendages.
- the composition according to the invention is an aqueous solution, more preferably an aqueous solution of slightly gelled appearance.
- the composition according to the invention is single-phase. This composition can be referred to as "serum".
- the term “serum” denotes a composition of fluid texture, of slightly gelled appearance, that is flowing, and preferably concentrated with ascorbic acid (i.e., at least 5% by weight of ascorbic acid).
- the composition according to the invention is substantially free from lipophilic phase.
- substantially free from lipophilic phase denotes that the composition according to the invention has a lipophilic phase content less than or equal to 2% by weight, with respect to the total weight of the composition, preferably less than or equal to 1% by weight, preferably less than or equal to 0.5% by weight.
- the composition according to the invention is totally free from lipophilic phase.
- lipophilic phase denotes a phase comprising at least one lipophilic compound chosen from oils and perfumes.
- the composition according to the invention is substantially free from surfactants.
- substantially free from surfactants denotes that the composition according to the invention has a surfactant content less than or equal to 2% by weight, with respect to the total weight of the composition, preferably less than or equal to 1% by weight.
- the surfactants can preferably be peptizing agents, the concentration of which is between 0.1 and 2% by weight, which enable the solubilization of a small quantity of oils, lipophilic compounds or perfume (i.e., perfume or oil concentration between 0.05% and 2% by weight).
- the composition according to this invention is transparent.
- the term transparent composition according to the present invention denotes a composition with a turbidity value of less than 200 NTU, preferably less than 150 NTU, preferably less than 100 NTU.
- the turbidity of the compositions is equal to at least 1 NTU.
- NTUs are units for measurement of the turbidity of a composition. The turbidity measurement is made, for example, with a model 21 OOP turbidity meter made by the Hach Company, the tubes used for the measurement being references AR397A cat 24347-06. The measurements are made at ambient temperature (from 20°C to 25°C).
- the composition is transparent and has a turbidity value between 1 and 200 NTU, preferably between 1 and 150 NTU, and preferably less than 100 NTU.
- composition according to the invention comprises a physiologically acceptable aqueous medium.
- Said phase comprises water.
- the water used can be sterile demineralized water and/or floral water such as rose water, cornflower water, chamomile water or linden water, and/or a spring or natural mineral water.
- the composition preferably comprises at least 30% by weight of water with respect to the total weight of the composition, preferably at least 40% by weight.
- the composition preferably comprises from 30% to 93% by weight of water with respect to the total weight of the composition, more preferably from 50% to 90%, even more preferably from 55% to 70%.
- the aqueous phase can also comprise at least one water-soluble organic solvent, at 25°C.
- the water-soluble organic solvent is chosen from alcohols, certain polyols and mixtures thereof.
- alcohols such as ethanol, isopropanol, propanol and butanol.
- the polyol is, preferably chosen from polyols having 2 to 20 carbon atoms, preferably 2 to 5 carbon atoms, such as glycerol, diglycerol, propylene glycol, isoprene glycol, dipropylene glycol, butylene glycol, 1 ,3-propanediol, pentylene glycol, polyethyleneglycols having 2 to 200 ethylene oxide units and mixtures thereof.
- the water-soluble organic solvent is a polyol such as glycerol.
- the composition comprises from 1% to 25% by weight of water-soluble organic solvent, with respect to the total weight of the composition, more preferably from 2% to 30% by weight, even more preferably from 5% to 20% by weight.
- composition comprising 5 to 7 carbon atoms
- the composition according to the invention also comprises at least 3.5% by weight in relation to the total weight of the composition of at least one glycol comprising 5 to 7 carbon atoms.
- glycol comprising 5 to 7 carbon atoms denotes a diol comprising a C5 to C7 carbon chain, devoid of ether function, and wherein the two hydroxyl groups are carried by different carbon atoms.
- the C5 to C7 carbon chain can be linear or branched.
- the glycol comprising 5 to 7 carbon atoms is hexylene glycol, also referred to as 2-methyl-2,4-pentanediol, or pentylene glycol (also referred to as pentane-1 ,2-diol).
- 2-methyl-2,4-pentanediol is different from 1 ,2-hexylene glycol by the location of the hydroxyl groups and by the carbon chain: the hydroxylated groups are positioned at 2 and 4 on the branched carbon chain for 2-methyl-2,4-pentanediol (hexylene glycol), while 1 ,2-hexylene glycol contains hydroxylated groups at 1 and 2 on the linear carbon chain.
- the glycol comprising 5 to 7 carbon atoms is present in the physiologically acceptable aqueous medium.
- the composition comprises at least 3.5% by weight of glycol comprising 5 to 7 carbon atoms with respect to the total weight of the composition. Preferably, it comprises from 4% to 15% by weight of glycol comprising 5 to 7 carbon atoms, more preferably from 5% to 10% by weight.
- composition according to the invention also comprises ascorbic acid or one of the derivatives thereof.
- the ascorbic acid according to the invention corresponds preferably to L-ascorbic acid, or vitamin C. Its structure is as in formula (I):
- corbic acid derivative preferably denotes a compound chosen from 5,6-di-O- dimethylsilylascorbate (particularly sold by Exsymol under the reference PRO-AA), DL- alpha-tocopheryl-DL-ascorbyl-phosphate potassium salt also referred to as Potassium Ascorbyl Tocopheryl Phosphate (sold by Senju Pharmaceutical under the reference SEPIVITAL EPC), magnesium ascorbyl phosphate, sodium ascorbyl phosphate (sold by Roche under the reference Stay-C 50), disodium ascorbyl sulfate, sulfinyl-L-ascorbic acid, glucopyranosyl-L-ascorbic acid and ascorbyl glucoside.
- ascorbyl glucoside denotes the condensation product of glucose, in D form, i.e., in the form of a or b glucopyrannose or a or b furanose, or in L form, with ascorbic acid, preferably in L form.
- the ascorbyl glucoside is L-ascorbic acid 2-O-a-D- glucopyranoside, particularly available from HAYASHIBARA.
- composition according to the invention comprises ascorbic acid, preferably L-ascorbic acid.
- the composition comprises at least 5% by weight of ascorbic acid or one of the derivatives thereof with respect to the total weight of the composition, preferably at least 8% by weight, more preferably at least 10% by weight.
- the composition comprises from 5% to 25% by weight of ascorbic acid or one of the derivatives thereof, with respect to the total weight of the composition, more preferably from 5% to 20% by weight, even more preferably from 9% to 17% by weight.
- Cationic polymer chosen from cationic cellulose polymers modified by oroups including at least one linear fattv chain
- the cationic polymer according to the invention is chosen from cationic cellulose polymers modified by groups including at least one linear fatty chain, preferably polyquaternium-67.
- the cationic polymer according to the invention is a cationic cellulose polymer modified by groups including at least one linear fatty chain.
- a "cationic cellulose polymer” denotes any non-siliconized (comprising no silicon atoms) cellulose polymer containing cationic groups and/or groups ionizable into cationic groups, and preferably not containing anionic groups and/or groups ionizable into anionic groups.
- cellulose denotes according to the invention any polysaccharide compound having in the structure thereof at least 20 glucose residue chains joined by b-1 ,4 bonds.
- the cellulose polymer can be associative, i.e., having the structure thereof at least one C8-C30 fatty chain.
- the cationic cellulose polymers suitable for use preferably have a weight-average molecular weight (Mw) between about 5000 and 5.10 6 , preferably between about 10 3 and 3.10 6 .
- Mw weight-average molecular weight
- cellulose ethers including quaternary ammonium groups modified by groups including at least one linear fatty chain.
- quaternary celluloses include at least one linear fatty chain, such as linear alkyl, linear or branched arylalkyl, linear alkylaryl, preferably linear alkyl, groups, these groups including at least 8 carbon atoms, particularly 8 to 30 carbon atoms, more preferably 10 to 24, or 10 to 14, carbon atoms; or mixtures thereof.
- groups including at least one linear fatty chain such as linear alkyl, linear or branched arylalkyl, linear alkylaryl, preferably linear alkyl, groups, these groups including at least 8 carbon atoms, particularly 8 to 30 carbon atoms, more preferably 10 to 24, or 10 to 14, carbon atoms; or mixtures thereof.
- quaternized hydroxyethylcelluloses modified by groups including at least one linear fatty chain, such as linear alkyl, linear arylalkyl, linear alkylaryl, preferably linear alkyl, groups, these groups including at least 8 carbon atoms, particularly 8 to 30 carbon atoms, more preferably 10 to 24, or 10 to 14, carbon atoms; or mixtures thereof.
- groups including at least one linear fatty chain such as linear alkyl, linear arylalkyl, linear alkylaryl, preferably linear alkyl, groups, these groups including at least 8 carbon atoms, particularly 8 to 30 carbon atoms, more preferably 10 to 24, or 10 to 14, carbon atoms; or mixtures thereof.
- R represents an ammonium group RaRbRcN+-, Q- wherein Ra, Rb, Rc, identical or different represent a hydrogen atom or linear, C1-C30, alkyl, preferably an alkyl and Q- represents an anionic counterion such as a halide such as chloride or bromide;
- R’ represents an ammonium group R’aR’bR’cN+-, Q’- wherein R’a, R’b, R’c, identical or different represent a hydrogen atom or linear, C1-C30, alkyl, preferably an alkyl and Q’- represents an anionic counterion such as a halide such as chloride or bromide; preferably an alkyl; it being understood that at least one of the radicals Ra, Rb, Rc, R’a, R’b, R’c represents a linear, C8-C30, alkyl;
- At least one of the radicals Ra, Rb, Rc, R’a, R’b, R’c represents a linear C8-C30 alkyl; preferably C10-C24, or C10-C14; mention can particularly be made of the dodecyl radical (C12).
- the or the other radicals represent a linear C1-C4 alkyl, particularly methyl.
- R can be a group chosen from -N + (CH 3 )3, Q’ and -N + (Ci2H 2 5)(CH 3 )2, Q’ , preferably a group -N + (CH 3 ) 3 , Q’ ⁇
- R’ can be a group -N + (Ci2H25)(CH 3 )2, Q’ ⁇
- the nitrogen percentage can vary from 0.1 to 10% by weight with respect to the total polymer weight, preferably from 0.2 to 5% by weight and more preferably from 0.5 to 3% by weight.
- Polyquaternium-24 such as the product QUATRISOFT LM 200®, marketed by AMERCHOL/DOW CHEMICAL;
- C12 alkyl Lauryldimonium Chloride (C12 alkyl), such as the product CRODACEL QL® and
- C18 alkyl such as the product CRODACEL QS®, marketed by CRODA.
- This type of polymer is known under the INCI name Polyquaternium-67; as commercial products, mention can be made of SOFTCAT POLYMER SL® polymers such as SL-100, SL-60, SL-30, SL-5 and SX- 1300X from AMERCHOL/DOW CHEMICAL.
- the cationic cellulose polymer is chosen from hydroxyethyl celluloses having reacted with a trimethyl ammonium epoxide and a lauryl dimethyl ammonium epoxide (INCI name POLYQUATERNIUM-67).
- Softcat Polymer SL-100 Softcat Polymer SX- 1300X by Amerchol.
- the composition comprises from 0.05% to 5% by weight of cationic polymer, with respect to the total weight of the composition, more preferably from 0.3% to 3% by weight, even more preferably from 0.4% to 2% by weight.
- pH of the composition The pH of the composition according to the invention is preferably 5.0 to 7.0.
- the pH of the composition is between 5.5 and 6.5.
- the cosmetic composition according to the invention comprises at least one base.
- the base is particularly used to increase the final pH of the composition to between 5.0 and 7.0, preferably between 5.5 and 6.5.
- the base can be chosen from mineral bases such as for example alkaline metal hydroxides, sodium hydroxide, potassium hydroxide.
- the base of the composition is an alkaline metal hydroxide, preferably sodium hydroxide or potassium hydroxide.
- these bases are more advantageous than nitrogenous bases, such as triethanolamine, on color stabilization (i.e., less yellowing).
- the base of the composition according to the invention is present in a base:ascorbic acid weight ratio ranging from 0.22 to 0.30.
- composition can also comprise one or more additive(s) conventionally used in cosmetic compositions such as for example active agents, sequestering agents, additional glycols different from the glycols comprising 5 to 7 carbon atoms cited above, preservatives or perfumes.
- additive(s) conventionally used in cosmetic compositions such as for example active agents, sequestering agents, additional glycols different from the glycols comprising 5 to 7 carbon atoms cited above, preservatives or perfumes.
- adenosine adenosine, salicylic acid, glycolic acid, niacinamide (Vitamin B3), tocopherol or perfumes are preferred.
- composition according to the invention can comprise at least one sequestering agent.
- sequestering agents mention can be made of ethylene diamine disuccinic acid.
- Ethylene diamine disuccinic acid is a compound of formula (II):
- the ethylene diamine disuccinic salt is chosen from alkaline metal salts, such as potassium salts and sodium salts, ammonium salts, and amine salts.
- alkaline metal salts of ethylene diamine acid are more particularly preferred.
- the ethylene diamine disuccinic acid salt used according to the invention is trisodium ethylene diamine disuccinate.
- Such a compound is for example that marketed under the name Natrlquest® E30 by Innospec Active Chemicals, or that marketed under the name Octaquest E30 ® by Octel Performance Chemicals.
- the composition according to the invention comprises from 0.01% to 2.5% by weight, preferably from 0.05% to 1 .5% by weight, more preferably from 0.07% to 0.3% by weight of ethylene diamine disuccinic acid salt, with respect to the total weight of the composition.
- ethylene diamine disuccinic acid salt corresponds to the active substance, also referred to as dry matter, content of ethylene diamine disuccinic acid salt introduced into the composition.
- the ethylene diamine disuccinic acid salt can be introduced into the composition dissolved in water, particularly at a content ranging from 25% to 50% by weight, preferably from 35% to 40% by weight in water.
- Such a compound is for example that marketed under the name Natrlquest® E30 by Innospec Active Chemicals, at 37% by weight in water.
- the composition according to the invention comprises at least one additional glycol different from the glycols comprising 5 to 7 carbon atoms cited above.
- a glycol is a glycol comprising 8 carbon atoms, preferably caprylyl glycol.
- composition according to the invention preferably comprises at least caprylyl glycol. Indeed, the presence of caprylyl glycol, coupled with the presence of at least 3.5% by weight of hexylene glycol, favors obtaining transparent compositions.
- the composition according to the invention comprises from 0.1% to 2% by weight, preferably from 0.5% to 1 .5% by weight, more preferably from 0.7% to 1 % by weight of glycol comprising 8 carbon atoms with respect to the total weight of the composition.
- the composition according to the invention comprises at least one preservative.
- preservatives mention can be made of hydroxyacetophenone, phenoxyethanol and mixtures thereof.
- the composition according to the invention comprises from 0.1% to 2% by weight, preferably from 0.5% to 1 .5% by weight, more preferably from 0.7% to 1 % by weight of preservative(s) with respect to the total weight of the composition.
- the invention also relates to a cosmetic method for cleansing keratin materials, preferably the skin, comprising the application of a composition according to the invention.
- the pressure in the examples is atmospheric pressure. Unless specified otherwise, the percentages are expressed by weight in relation to the total weight of the composition (% w/w).
- Example 1 Compositions according to the invention
- phase A In a first beaker (phase A):
- phase B In a second beaker (phase B):
- Example 2 Influence of different ingredients on soaping of aqueous formulas comprisina at 10% ascorbic acid and 0.5% polvauaternium-67
- phase B In a second beaker (phase B):
- compositions The appearance of the compositions is evaluated with the naked eye.
- the test was performed blind on 6 people. Soaping was evaluated by applying one drop of product on the hand and shearing quickly with the other hand until the product has penetrated.
- Adding propylene glycol, dipropylene glycol or butylene glycol does not reduce soaping.
- Hexylene glycol has the advantage of reducing soaping, or eliminating soaping, at a concentration greater than or equal to 3.5% by weight in the formula.
- pentylene glycol at a concentration greater than or equal to 3.5% by weight in the formula, has not only the advantage of reducing or even eliminating soaping, but also of solubilizing caprylyl glycol to promote serum transparency.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a cosmetic composition comprising, in a physiologically acceptable aqueous medium: - at least 5% by weight of ascorbic acid or one of the derivatives thereof, - at least 3.5% by weight with respect to the total weight of the composition of at least one glycol comprising 5 to 7 carbon atoms, - at least one cationic polymer chosen from cationic cellulose polymers modified by groups including at least one linear fatty chain.
Description
Transparent cosmetic composition with ascorbic acid, a cationic polymer and a glycol
The present invention relates to an aqueous transparent cosmetic composition, comprising at least 5% by weight of ascorbic acid and/or one of the derivatives thereof, at least 3.5% by weight of a glycol comprising 5 to 7 carbon atoms and at least one cationic polymer chosen from cationic cellulose polymers modified by groups including at least one linear fatty chain.
In cosmetic applications, it is routine to add ascorbic acid (vitamin C) as a skin regenerating agent thanks to stimulation of collagen synthesis responsible for skin firmness, or as a depigmenting agent, as this vitamin lowers the production of melanin responsible for brown spots. Ascorbic acid is also known for the antioxidant properties thereof.
However, when ascorbic acid or one of the derivatives thereof is introduced into an aqueous medium at high levels (i.e., for example greater than 1% by weight, preferably greater than 5% by weight), the formulation thereof is difficult to carry out, as it destabilizes and changes color dramatically.
For this reason, serum or solution type aqueous compositions, which comprise ascorbic acid in the form of powder to be solubilized extemporaneously, are found on the market. The drawback of this type of products is that vitamin C eventually degrades in the aqueous medium. These products thus lose their appeal as consumers prefer, for practical reasons, serums with no prior handling, with the guarantee of color stability and with no chemical degradation.
Therefore there is a need for stable aqueous compositions comprising ascorbic acid. It is possible to gel the aqueous phase of such compositions by means of a specific cationic polymer, preferably polyquaternium-67. This polymer has the triple advantage of adding viscosity to the medium and leaving a soft film on the skin and reducing the degradation of the color of ascorbic acid over time.
However, these serum or gelled solution type aqueous compositions have nevertheless the drawback of forming, when spread on the skin, a non-homogeneous deposit, which whitens
during shearing, and which is not satisfactory for the consumer. Such whitening is referred to as "soaping" in the present application.
There is therefore a need for an aqueous cosmetic composition comprising ascorbic acid and/or one of the derivatives thereof, which is stable, i.e., which stays the same color as originally (generally white) and the same texture, which does not degrade the active agent, and which does not exhibit soaping when applied.
Surprisingly, the Applicant demonstrated that associating a specific cationic polymer with hexylene glycol and/or pentylene glycol at a content of at least 3.5% by weight with respect to the total composition weight, makes it possible to obtain compositions comprising at least 5% by weight of ascorbic acid and/or one of the derivatives thereof, which are stable, and which do not exhibit soaping when applied.
Thus, the present invention relates to a cosmetic composition comprising, in a physiologically acceptable aqueous medium:
- at least 5% by weight of ascorbic acid or one of the derivatives thereof,
- at least 3.5% by weight with respect to the total weight of the composition of at least one glycol comprising 5 to 7 carbon atoms,
- at least one cationic polymer chosen from cationic cellulose polymers modified by groups including at least one linear fatty chain, the percentages being by weight with respect to the total composition weight.
Preferably, the composition has a pH between 5 and 7.
The invention also relates to a cosmetic method for the care of keratin materials, preferably the skin, comprising the application of a composition according to the invention on said keratin materials.
The term "physiologically acceptable medium" denotes a medium comprising water and compatible with the skin, mucosa and/or appendages.
Preferably, the composition according to the invention is an aqueous solution, more preferably an aqueous solution of slightly gelled appearance. Preferably, the composition according to the invention is single-phase. This composition can be referred to as "serum". The term "serum" denotes a composition of fluid texture, of slightly gelled appearance, that
is flowing, and preferably concentrated with ascorbic acid (i.e., at least 5% by weight of ascorbic acid).
Preferably, the composition according to the invention is substantially free from lipophilic phase. The term "substantially free from lipophilic phase" denotes that the composition according to the invention has a lipophilic phase content less than or equal to 2% by weight, with respect to the total weight of the composition, preferably less than or equal to 1% by weight, preferably less than or equal to 0.5% by weight. Preferably, the composition according to the invention is totally free from lipophilic phase.
The term "lipophilic phase" denotes a phase comprising at least one lipophilic compound chosen from oils and perfumes.
Preferably, the composition according to the invention is substantially free from surfactants. The term "substantially free from surfactants" denotes that the composition according to the invention has a surfactant content less than or equal to 2% by weight, with respect to the total weight of the composition, preferably less than or equal to 1% by weight.
The surfactants can preferably be peptizing agents, the concentration of which is between 0.1 and 2% by weight, which enable the solubilization of a small quantity of oils, lipophilic compounds or perfume (i.e., perfume or oil concentration between 0.05% and 2% by weight).
Preferably, the composition according to this invention is transparent.
The term transparent composition according to the present invention denotes a composition with a turbidity value of less than 200 NTU, preferably less than 150 NTU, preferably less than 100 NTU. Preferably, the turbidity of the compositions is equal to at least 1 NTU. NTUs (nephelometric turbidity units) are units for measurement of the turbidity of a composition. The turbidity measurement is made, for example, with a model 21 OOP turbidity meter made by the Hach Company, the tubes used for the measurement being references AR397A cat 24347-06. The measurements are made at ambient temperature (from 20°C to 25°C).
Preferably, the composition is transparent and has a turbidity value between 1 and 200 NTU, preferably between 1 and 150 NTU, and preferably less than 100 NTU.
The composition according to the invention comprises a physiologically acceptable aqueous medium. Said phase comprises water.
The water used can be sterile demineralized water and/or floral water such as rose water, cornflower water, chamomile water or linden water, and/or a spring or natural mineral water.
The composition preferably comprises at least 30% by weight of water with respect to the total weight of the composition, preferably at least 40% by weight.
The composition preferably comprises from 30% to 93% by weight of water with respect to the total weight of the composition, more preferably from 50% to 90%, even more preferably from 55% to 70%.
The aqueous phase can also comprise at least one water-soluble organic solvent, at 25°C.
Preferably, the water-soluble organic solvent is chosen from alcohols, certain polyols and mixtures thereof.
Among the alcohols, mention can be made of C1-C10, more preferably C1-C5, alcohols, such as ethanol, isopropanol, propanol and butanol.
The polyol is, preferably chosen from polyols having 2 to 20 carbon atoms, preferably 2 to 5 carbon atoms, such as glycerol, diglycerol, propylene glycol, isoprene glycol, dipropylene glycol, butylene glycol, 1 ,3-propanediol, pentylene glycol, polyethyleneglycols having 2 to 200 ethylene oxide units and mixtures thereof.
Preferably, the water-soluble organic solvent is a polyol such as glycerol.
Preferably, the composition comprises from 1% to 25% by weight of water-soluble organic solvent, with respect to the total weight of the composition, more preferably from 2% to 30% by weight, even more preferably from 5% to 20% by weight.
Glycol comprising 5 to 7 carbon atoms The composition according to the invention also comprises at least 3.5% by weight in relation to the total weight of the composition of at least one glycol comprising 5 to 7 carbon atoms.
The term glycol comprising 5 to 7 carbon atoms denotes a diol comprising a C5 to C7 carbon chain, devoid of ether function, and wherein the two hydroxyl groups are carried by different carbon atoms. The C5 to C7 carbon chain can be linear or branched.
Preferably, the glycol comprising 5 to 7 carbon atoms is hexylene glycol, also referred to as 2-methyl-2,4-pentanediol, or pentylene glycol (also referred to as pentane-1 ,2-diol). 2-methyl-2,4-pentanediol is different from 1 ,2-hexylene glycol by the location of the hydroxyl groups and by the carbon chain: the hydroxylated groups are positioned at 2 and 4 on the branched carbon chain for 2-methyl-2,4-pentanediol (hexylene glycol), while 1 ,2-hexylene glycol contains hydroxylated groups at 1 and 2 on the linear carbon chain.
The glycol comprising 5 to 7 carbon atoms is present in the physiologically acceptable aqueous medium.
The composition comprises at least 3.5% by weight of glycol comprising 5 to 7 carbon atoms with respect to the total weight of the composition. Preferably, it comprises from 4% to 15% by weight of glycol comprising 5 to 7 carbon atoms, more preferably from 5% to 10% by weight.
Ascorbic acid or derivatives thereof
The composition according to the invention also comprises ascorbic acid or one of the derivatives thereof.
The ascorbic acid according to the invention corresponds preferably to L-ascorbic acid, or vitamin C. Its structure is as in formula (I):
The term "ascorbic acid derivative" preferably denotes a compound chosen from 5,6-di-O- dimethylsilylascorbate (particularly sold by Exsymol under the reference PRO-AA), DL- alpha-tocopheryl-DL-ascorbyl-phosphate potassium salt also referred to as Potassium Ascorbyl Tocopheryl Phosphate (sold by Senju Pharmaceutical under the reference SEPIVITAL EPC), magnesium ascorbyl phosphate, sodium ascorbyl phosphate (sold by Roche under the reference Stay-C 50), disodium ascorbyl sulfate, sulfinyl-L-ascorbic acid, glucopyranosyl-L-ascorbic acid and ascorbyl glucoside.
The term "ascorbyl glucoside" denotes the condensation product of glucose, in D form, i.e., in the form of a or b glucopyrannose or a or b furanose, or in L form, with ascorbic acid,
preferably in L form. Preferably, the ascorbyl glucoside is L-ascorbic acid 2-O-a-D- glucopyranoside, particularly available from HAYASHIBARA.
Preferably, the composition according to the invention comprises ascorbic acid, preferably L-ascorbic acid.
The composition comprises at least 5% by weight of ascorbic acid or one of the derivatives thereof with respect to the total weight of the composition, preferably at least 8% by weight, more preferably at least 10% by weight.
Preferably, the composition comprises from 5% to 25% by weight of ascorbic acid or one of the derivatives thereof, with respect to the total weight of the composition, more preferably from 5% to 20% by weight, even more preferably from 9% to 17% by weight.
Cationic polymer chosen from cationic cellulose polymers modified by oroups including at least one linear fattv chain The cationic polymer according to the invention is chosen from cationic cellulose polymers modified by groups including at least one linear fatty chain, preferably polyquaternium-67.
The cationic polymer according to the invention is a cationic cellulose polymer modified by groups including at least one linear fatty chain. According to the present invention, a "cationic cellulose polymer" denotes any non-siliconized (comprising no silicon atoms) cellulose polymer containing cationic groups and/or groups ionizable into cationic groups, and preferably not containing anionic groups and/or groups ionizable into anionic groups. The term "cellulose" polymer denotes according to the invention any polysaccharide compound having in the structure thereof at least 20 glucose residue chains joined by b-1 ,4 bonds. The cellulose polymer can be associative, i.e., having the structure thereof at least one C8-C30 fatty chain.
The cationic cellulose polymers suitable for use preferably have a weight-average molecular weight (Mw) between about 5000 and 5.106, preferably between about 103 and 3.106. Among the cationic celluloses, mention can more particularly be made of cellulose ethers including quaternary ammonium groups modified by groups including at least one linear fatty chain.
Among the quaternary celluloses, mention can be made in particular of quaternized celluloses modified by groups including at least one linear fatty chain, such as linear alkyl, linear or branched arylalkyl, linear alkylaryl, preferably linear alkyl, groups, these groups
including at least 8 carbon atoms, particularly 8 to 30 carbon atoms, more preferably 10 to 24, or 10 to 14, carbon atoms; or mixtures thereof.
Preferably, mention can be made of quaternized hydroxyethylcelluloses modified by groups including at least one linear fatty chain, such as linear alkyl, linear arylalkyl, linear alkylaryl, preferably linear alkyl, groups, these groups including at least 8 carbon atoms, particularly 8 to 30 carbon atoms, more preferably 10 to 24, or 10 to 14, carbon atoms; or mixtures thereof.
Preferably, mention can be made of hydroxyethy lcel I u loses of formula (lb):
- R represents an ammonium group RaRbRcN+-, Q- wherein Ra, Rb, Rc, identical or different represent a hydrogen atom or linear, C1-C30, alkyl, preferably an alkyl and Q- represents an anionic counterion such as a halide such as chloride or bromide;
- R’ represents an ammonium group R’aR’bR’cN+-, Q’- wherein R’a, R’b, R’c, identical or different represent a hydrogen atom or linear, C1-C30, alkyl, preferably an alkyl and Q’- represents an anionic counterion such as a halide such as chloride or bromide; preferably an alkyl; it being understood that at least one of the radicals Ra, Rb, Rc, R’a, R’b, R’c represents a linear, C8-C30, alkyl;
- n, x and y, identical or different, represent an integer between 1 and 10000. Preferably, in formula (lb), at least one of the radicals Ra, Rb, Rc, R’a, R’b, R’c represents a linear C8-C30 alkyl; preferably C10-C24, or C10-C14; mention can particularly be made of the dodecyl radical (C12). Preferably, the or the other radicals represent a linear C1-C4 alkyl, particularly methyl.
Preferably, in formula (lb), only one of the radicals Ra, Rb, Rc, R’a, R’b, R’c represents a linear, C8-C30 alkyl; preferably C10-C24, or C10-C14; mention can particularly be made of the dodecyl radical (C12). Preferably, all the other radicals represent a linear C1-C4 alkyl, particularly methyl.
More preferably, R can be a group chosen from -N+(CH3)3, Q’ and -N+(Ci2H25)(CH3)2, Q’ , preferably a group -N+(CH3)3, Q’\
More preferably, R’ can be a group -N+(Ci2H25)(CH3)2, Q’\
The nitrogen percentage can vary from 0.1 to 10% by weight with respect to the total polymer weight, preferably from 0.2 to 5% by weight and more preferably from 0.5 to 3% by weight.
Mention can particularly be made of polymers having the INCI names:
- Polyquaternium-24, such as the product QUATRISOFT LM 200®, marketed by AMERCHOL/DOW CHEMICAL;
- PG-Hydroxyethylcellulose Cocodimonium Chloride, such as the product CRODACEL QM®;
- PG-Hydroxyethylcellulose Lauryldimonium Chloride (C12 alkyl), such as the product CRODACEL QL® and
- PG-Hydroxyethylcellulose Stearyldimonium Chloride (C18 alkyl) such as the product CRODACEL QS®, marketed by CRODA.
Mention can also be made of hydroxyethylcelluloses of formula (lb) wherein R represents trimethylammonium halide and R’ represents dimethyldodecylammonium halide, preferably R represents trimethylammonium chloride CI-,(CH3)3N+- and R’ represents dimethyldodecylammonium chloride CI-,(CH3)2(C12H25)N+- . This type of polymer is known under the INCI name Polyquaternium-67; as commercial products, mention can be made of SOFTCAT POLYMER SL® polymers such as SL-100, SL-60, SL-30, SL-5 and SX- 1300X from AMERCHOL/DOW CHEMICAL.
More particularly, the cationic cellulose polymer is chosen from hydroxyethyl celluloses having reacted with a trimethyl ammonium epoxide and a lauryl dimethyl ammonium epoxide (INCI name POLYQUATERNIUM-67).
It is preferably marketed under the name Softcat Polymer SL-100 or Softcat Polymer SX- 1300X by Amerchol.
Preferably, the composition comprises from 0.05% to 5% by weight of cationic polymer, with respect to the total weight of the composition, more preferably from 0.3% to 3% by weight, even more preferably from 0.4% to 2% by weight. pH of the composition
The pH of the composition according to the invention is preferably 5.0 to 7.0. Advantageously, the pH of the composition is between 5.5 and 6.5.
Preferably, the cosmetic composition according to the invention comprises at least one base.
The base is particularly used to increase the final pH of the composition to between 5.0 and 7.0, preferably between 5.5 and 6.5.
The base can be chosen from mineral bases such as for example alkaline metal hydroxides, sodium hydroxide, potassium hydroxide.
Preferably, the base of the composition is an alkaline metal hydroxide, preferably sodium hydroxide or potassium hydroxide. Indeed, these bases are more advantageous than nitrogenous bases, such as triethanolamine, on color stabilization (i.e., less yellowing).
Preferably, the base of the composition according to the invention is present in a base:ascorbic acid weight ratio ranging from 0.22 to 0.30.
The composition can also comprise one or more additive(s) conventionally used in cosmetic compositions such as for example active agents, sequestering agents, additional glycols different from the glycols comprising 5 to 7 carbon atoms cited above, preservatives or perfumes.
Preferably, among the usable active agents, adenosine, salicylic acid, glycolic acid, niacinamide (Vitamin B3), tocopherol or perfumes are preferred.
The composition according to the invention can comprise at least one sequestering agent. Among the preferred sequestering agents, mention can be made of ethylene diamine disuccinic acid. Ethylene diamine disuccinic acid is a compound of formula (II):
[Chem 3]
Preferably, the ethylene diamine disuccinic salt is chosen from alkaline metal salts, such as potassium salts and sodium salts, ammonium salts, and amine salts. The alkaline metal salts of ethylene diamine acid are more particularly preferred.
Preferably, the ethylene diamine disuccinic acid salt used according to the invention is trisodium ethylene diamine disuccinate.
Such a compound is for example that marketed under the name Natrlquest® E30 by Innospec Active Chemicals, or that marketed under the name Octaquest E30® by Octel Performance Chemicals.
Preferably, the composition according to the invention comprises from 0.01% to 2.5% by weight, preferably from 0.05% to 1 .5% by weight, more preferably from 0.07% to 0.3% by weight of ethylene diamine disuccinic acid salt, with respect to the total weight of the composition.
It is understood that the ethylene diamine disuccinic acid salt corresponds to the active substance, also referred to as dry matter, content of ethylene diamine disuccinic acid salt introduced into the composition.
According to a specific embodiment, the ethylene diamine disuccinic acid salt can be introduced into the composition dissolved in water, particularly at a content ranging from 25% to 50% by weight, preferably from 35% to 40% by weight in water.
Such a compound is for example that marketed under the name Natrlquest® E30 by Innospec Active Chemicals, at 37% by weight in water.
Preferably, the composition according to the invention comprises at least one additional glycol different from the glycols comprising 5 to 7 carbon atoms cited above. Preferably, such a glycol is a glycol comprising 8 carbon atoms, preferably caprylyl glycol.
The composition according to the invention preferably comprises at least caprylyl glycol. Indeed, the presence of caprylyl glycol, coupled with the presence of at least 3.5% by weight of hexylene glycol, favors obtaining transparent compositions.
Preferably, the composition according to the invention comprises from 0.1% to 2% by weight, preferably from 0.5% to 1 .5% by weight, more preferably from 0.7% to 1 % by weight of glycol comprising 8 carbon atoms with respect to the total weight of the composition.
Preferably, the composition according to the invention comprises at least one preservative.
Among the preferred preservatives, mention can be made of hydroxyacetophenone, phenoxyethanol and mixtures thereof.
Preferably, the composition according to the invention comprises from 0.1% to 2% by weight, preferably from 0.5% to 1 .5% by weight, more preferably from 0.7% to 1 % by weight of preservative(s) with respect to the total weight of the composition.
Finally, the invention also relates to a cosmetic method for cleansing keratin materials, preferably the skin, comprising the application of a composition according to the invention.
Concrete, yet non-limiting, examples, illustrating the invention, will now be provided.
EXAMPLES
Unless stated otherwise, the pressure in the examples is atmospheric pressure. Unless specified otherwise, the percentages are expressed by weight in relation to the total weight of the composition (% w/w).
Example 1 : Compositions according to the invention
Formulas A and B according to the invention are prepared below according to the following protocol:
In a first beaker (phase A):
1. Introduce water (T>60°C) and add the ingredients of phase Ain the following order: glycerin, caprylyl glycol, trisodium ethylene diamine disuccinate, hexylene glycol or pentylene glycol at 60°C;
2. Once everything has dissolved and there are no more crystals, allow to cool.
In a second beaker (phase B):
1 . Introduce water at ambient temperature and add ascorbic acid;
2. Adjust the pH to 5.8 with sodium hydroxide;
3. Add polyquaternium-67 with moderate, lengthy stirring to ensure effective deployment of the polymer.
Mix the two beakers (pour phase A into phase B) and make up to the QS with water if required.
[Table 1]
Example 2: Influence of different ingredients on soaping of aqueous formulas comprisina at 10% ascorbic acid and 0.5% polvauaternium-67
The following comparative compositions are prepared with the following protocol:
Formulas A and B according to the invention are prepared below according to the following protocol: In a first beaker (phase A):
1. Introduce water (T>60°C) and add the ingredients of phase Ain the following order: glycerin, caprylyl glycol, trisodium ethylene diamine disuccinate, hexylene glycol or pentylene glycol at 60°C;
2. Once everything has dissolved and there are no more crystals, allow to cool.
In a second beaker (phase B):
1 . Introduce water at ambient temperature and add ascorbic acid;
2. Adjust the pH to 5.8 with sodium hydroxide;
3. Add polyquaternium-67 with moderate, lengthy stirring to ensure effective deployment of the polymer.
Mix the two beakers and make up to the QS with water if required.
The appearance of the compositions is evaluated with the naked eye.
The effect on soaping was evaluated as follows:
The test was performed blind on 6 people. Soaping was evaluated by applying one drop of product on the hand and shearing quickly with the other hand until the product has penetrated.
Finally, the stability of the compositions was evaluated up to 2 months at 45°C. Comparative examples C1 to C4- effect of oils [Table 2]
Adding isopropyl myristate makes it possible to eliminate soaping, but the formulas are unstable. Comparative examples C5 to C8- effect of silicone compounds
Adding silicone compounds, soluble in the composition, does not eliminate soaping. Comparative examples C9 to C11 - effect of Nad or glycerol
Adding NaCI or glycerin does not reduce soaping.
Comparative examples C12 to C14- effect of ethanol
Adding ethanol does not reduce soaping.
Comparative example C15- effect of methyl gluceth-20
Adding methyl gluceth-20 does not eliminate soaping.
Comparative examples C16 to C19- effect of oolvols
Adding propylene glycol, dipropylene glycol or butylene glycol does not reduce soaping.
Examples according to the invention ( C and D) and comparative example C20 effect of hexylene glycol
Hexylene glycol has the advantage of reducing soaping, or eliminating soaping, at a concentration greater than or equal to 3.5% by weight in the formula. Examples according to the invention (A and B) and comparative examples C12 and C21 - effect of hexylene alvcol
[Table 10]
Surprisingly, only hexylene glycol, at a concentration greater than or equal to 3.5% by weight in the formula, has not only the advantage of reducing or even eliminating soaping, but also of solubilizing caprylyl glycol to promote serum transparency.
Example E according to the invention and comparative example C22 - effect of pentylene glycol
Surprisingly, pentylene glycol, at a concentration greater than or equal to 3.5% by weight in the formula, has not only the advantage of reducing or even eliminating soaping, but also of solubilizing caprylyl glycol to promote serum transparency.
Claims
1. Cosmetic composition comprising, in a physiologically acceptable aqueous medium:
- at least 5% by weight of ascorbic acid and/or one of the derivatives thereof,
- at least 3.5% by weight with respect to the total weight of the composition of at least one glycol comprising 5 to 7 carbon atoms,
- at least one cationic polymer chosen from cationic cellulose polymers modified by groups including at least one linear fatty chain, the percentages being by weight with respect to the total composition weight.
2. Composition according to claim 1 , wherein the ascorbic acid derivative is chosen from 5,6-di-O-dimethylsilylascorbate, DL-alpha-tocopheryl-DL-ascorbyl-phosphate potassium salt, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, disodium ascorbyl sulfate, sulfinyl-L-ascorbic acid, glucopyranosyl-L-ascorbic acid and ascorbyl glucoside.
3. Composition according to claim 1 or 2, characterized in that it comprises at least 30% by weight of water with respect to the total weight of the composition, preferably at least 40% by weight, preferably from 30% to 93% by weight, more preferably from 50% to 90%, even more preferably from 55% to 70%.
4. Composition according to one of claims 1 to 3, characterized in that it comprises from 4% to 15% by weight of at least one glycol comprising 5 to 7 carbon atoms with respect to the total weight of the composition, preferably from 5% to 10% by weight.
5. Composition according to one of claims 1 to 4, characterized in that the glycol comprising 5 to 7 carbon atoms is hexylene glycol or pentylene glycol, preferably hexylene glycol.
6. Composition according to one of claims 1 to 5, characterized in that it comprises at least 5% by weight of ascorbic acid or one of the derivatives thereof with respect to the total weight of the composition, preferably at least 8% by weight, more preferably at least 10% by weight, preferably from 5% to 25% by weight, more preferably from 5% to 20% by weight, even more preferably from 9% to 17% by weight.
7. Composition according to one of claims 1 to 6, characterized in that it comprises from 0.05% to 5% by weight of cationic polymer, with respect to the total weight of the composition, more preferably from 0.3% to 3%, even more preferably from 0.4% to 2% by weight.
8. Composition according to one of claims 1 to 7, characterized in that the cationic polymer is chosen from quaternized hydroxyethylcelluloses modified by groups including at least one linear fatty chain; preferably from hydroxyethylcelluloses of formula (lb) wherein R represents trimethylammonium halide and R’ represents dimethyldodecylammonium halide:
9. Composition according to one of claims 1 to 8, characterized in that it has a pH from 5.0 to 7.0, preferably between 5.5 and 6.5.
10. Composition according to one of claims 1 to 9, characterized in that it is substantially free from lipophilic phase, preferably totally free from lipophilic phase.
11. Composition according to one of claims 1 to 10, characterized in that it is transparent.
12. Composition according to one of claims 1 to 11 , characterized in that it comprises at least one additional glycol different from the glycols comprising 5 to 7 carbon atoms cited above, preferably at least one glycol comprising 8 carbon atoms, preferably at least caprylyl glycol.
13. A cosmetic method for cleansing keratin materials, preferably the skin, comprising the application of a composition according to one of claims 1 to 12 onto said keratin materials.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2106894A FR3124390A1 (en) | 2021-06-28 | 2021-06-28 | Transparent cosmetic composition with ascorbic acid, cationic polymer and glycol |
FRFR2106894 | 2021-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023275046A1 true WO2023275046A1 (en) | 2023-01-05 |
Family
ID=77710990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/067721 WO2023275046A1 (en) | 2021-06-28 | 2022-06-28 | Transparent cosmetic composition with ascorbic acid, a cationic polymer and a glycol |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3124390A1 (en) |
WO (1) | WO2023275046A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024128168A1 (en) * | 2022-12-15 | 2024-06-20 | L'oreal | Composition comprising electrolyte and combination of polysaccharides |
WO2024133219A1 (en) * | 2022-12-19 | 2024-06-27 | L'oreal | Transparent cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one polyoxylenated alkylether dimethylsilane compound |
WO2024133115A1 (en) * | 2022-12-19 | 2024-06-27 | L'oreal | Cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one oxyalkylenated derivative |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3145280A1 (en) * | 2023-01-27 | 2024-08-02 | L'oreal | COMPOSITION COMPRISING AN ELECTROLYTE AND A COMBINATION OF POLYSACCHARIDES |
FR3143352A1 (en) * | 2022-12-19 | 2024-06-21 | L'oreal | Transparent cosmetic composition with ascorbic acid, a specific cationic polymer, and at least hydrophobic silica airgel particles |
FR3143349A1 (en) * | 2022-12-19 | 2024-06-21 | L'oreal | Transparent cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one heterogeneous polyholoside comprising at least one fucose unit |
FR3143351A1 (en) * | 2022-12-19 | 2024-06-21 | L'oreal | Transparent cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one crosslinked sodium polyacrylate |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1077066A1 (en) * | 1998-05-15 | 2001-02-21 | Showa Denko Kabushiki Kaisha | Preventives/remedies for skin diseases |
US20020034548A1 (en) * | 1998-12-31 | 2002-03-21 | James Parr | Stabilized ascorbic composition |
US20070140998A1 (en) * | 2003-10-14 | 2007-06-21 | Showa Denko K.K. | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer |
CN107496191A (en) * | 2017-10-13 | 2017-12-22 | 中国热带农业科学院热带作物品种资源研究所 | A kind of water lily plant polypeptide replenishing water and preserving moisture facial mask essence and preparation method thereof |
-
2021
- 2021-06-28 FR FR2106894A patent/FR3124390A1/en active Pending
-
2022
- 2022-06-28 WO PCT/EP2022/067721 patent/WO2023275046A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1077066A1 (en) * | 1998-05-15 | 2001-02-21 | Showa Denko Kabushiki Kaisha | Preventives/remedies for skin diseases |
US20020034548A1 (en) * | 1998-12-31 | 2002-03-21 | James Parr | Stabilized ascorbic composition |
US20070140998A1 (en) * | 2003-10-14 | 2007-06-21 | Showa Denko K.K. | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer |
CN107496191A (en) * | 2017-10-13 | 2017-12-22 | 中国热带农业科学院热带作物品种资源研究所 | A kind of water lily plant polypeptide replenishing water and preserving moisture facial mask essence and preparation method thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024128168A1 (en) * | 2022-12-15 | 2024-06-20 | L'oreal | Composition comprising electrolyte and combination of polysaccharides |
WO2024133219A1 (en) * | 2022-12-19 | 2024-06-27 | L'oreal | Transparent cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one polyoxylenated alkylether dimethylsilane compound |
WO2024133115A1 (en) * | 2022-12-19 | 2024-06-27 | L'oreal | Cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one oxyalkylenated derivative |
Also Published As
Publication number | Publication date |
---|---|
FR3124390A1 (en) | 2022-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023275046A1 (en) | Transparent cosmetic composition with ascorbic acid, a cationic polymer and a glycol | |
WO2023275073A1 (en) | Transparent cosmetic composition with ascorbic acid and a specific cationic polymer | |
EP2402000B1 (en) | Low-irritating, clear cleansing compositions with relatively low pH | |
KR20130088836A (en) | Low-irritating, clear cleansing compositions with relatively low ph | |
JP2023504170A (en) | Transparent composition with soluble scalp health active | |
EA022230B1 (en) | Clear liquid composition comprising alkanoyl glycinate, amphoteric, alkyl sulfate and specific acrylate polymers | |
KR101421751B1 (en) | Skin cleansing composition | |
PL207577B1 (en) | Detergent cosmetic compositions and use | |
WO2023275083A1 (en) | Transparent cosmetic composition with ascorbic acid and water-soluble uv screening agent | |
JP5865622B2 (en) | External preparation for skin and method for producing the same | |
JP5865623B2 (en) | External preparation for skin and method for producing the same | |
JP5191026B2 (en) | Cleaning composition | |
WO2024133115A1 (en) | Cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one oxyalkylenated derivative | |
WO2024133219A1 (en) | Transparent cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one polyoxylenated alkylether dimethylsilane compound | |
JP2013508310A (en) | Transparent cosmetic composition | |
JP2021187738A (en) | Cosmetic | |
JP5865624B2 (en) | External preparation for skin and method for producing the same | |
US11938202B2 (en) | Personal cleansing soap bar composition | |
FR3143349A1 (en) | Transparent cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one heterogeneous polyholoside comprising at least one fucose unit | |
JP2566446B2 (en) | Transparent detergent composition | |
WO2024127414A1 (en) | A cosmetic composition for acne control and methods thereof | |
FR3143351A1 (en) | Transparent cosmetic composition with ascorbic acid, a specific cationic polymer, and at least one crosslinked sodium polyacrylate | |
WO2023158591A1 (en) | Personal care pod | |
JP2023049461A (en) | Liquid skin external composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22740811 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22740811 Country of ref document: EP Kind code of ref document: A1 |